By studying the gaze of experts as they assess images of the eye, data scientist Kaveri Thakoor has improved AI methods for glaucoma detection and developed a new way to instruct trainees.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Most people are familiar with melanoma as a skin cancer, but melanoma can impact the eyes as well. Brian Marr, MD, offers tips on how to protect your eyes.
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.
Columbia researchers have found hundreds of genes linked to nearsightedness, and now they’re using the data to screen for new drugs that can safeguard sharp vision.
Vagelos student Emery Jamerson’19 received the 2018 Dr. David K. McDonogh Scholarship in Ophthalmology/ENT, named for the first black Columbia-trained doctor in New York.
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.
The discovery of genes that control eye growth gives researchers critical information in the search for drugs that can prevent nearsightedness, the world’s most common eye disorder.